Hello Malaysian Mooers! We are excited to announce that our FPX Express Deposit is now available!
From now on, choose the FPX transfer method and experience the funds arriving within 5 minutes, making your trading experience smoother~
📚 Learn how to use FPX to deposit funds in one minute
> Click here to learn more about this feature <
🗳️ Quick poll: Are you ready to experience FPX Express Deposit to trade
Discuss your i...

$TGUAN(7034.MY)$ $BPPLAS(5100.MY)$ $SLP(7248.MY)$
SCIENTX announced its results in March. Although the profit of the packaging business declined year by year, the forecast is that it will recover in the future. According to investment bank tracking, TGUAN also mentioned that demand will begin to recover this year.
However, BPPLAS's net profit in FY2023 has grown 15.4% year-on-year, so this year's stock price increase was the most aggressive. Today, SLP announced its latest results. Net profit was a six-quarter high, and YOY grew 63.1%. Turnover did not grow much, but as the product mix improved and raw material costs declined, margin increased a lot.
2023 was a difficult year for many manufacturing industries, mainly because customers bought too many products before, so last year they were out of stock. The situation has improved this year, exports have begun to recover, and the packaging industry will usher in a good year.
It is expected that the next performance of the above 4 packaging companies will turn upwards from the bottom. In an environment where the industry is strong and the packaging business is recovering, SCIENTX is also a bit closer to a long-term market capitalization of RM 10 billion.
Earnings are expected to recover, and stock prices have already set sail in the past month. As long as profits can be met, I believe the value of these companies will also be seen by more investors. Mutual encouragement.

$Tesla(TSLA.US)$ Quick summary:
- Elon announced an affordable model by early 2025 (possibly end 2024).
- Q1 profit, revenue, and margins drop way below forecasts.
- Global vehicle inventory increases to 28 days (from 15 days).
- TSLA rallied upon optimism on new models, despite an underwhelming quarter.
Tesla recently reported a significant 55% drop in Q1 profits and a 9% decline in revenue, and it caused mixed emotions within investors. However, during the earnin...

After years of researches and studies , finally TauRx released the full results and presentation of Phase 3 clinical studies of the flagship medicine named HMTM .
$GENTING(3182.MY)$ is having a 20% stake in TauRx , in which it is currently not making profits as the principal product HMTM is still under development and yet to be commercialized.
With the data released from the clinical trials , it is likely that TauRx’s HMTM will get the approvals from authority of key...

Add this name to my portfolio, filled gap with pin bar.  high RS97 and enormous volume.
$Palantir(PLTR.US)$